Inflammatory bowel diseases represent a complex array of diseases of incompletely known
etiology that led to gastrointestinal tract chronic inflammation. In inflammatory bowel …

The human gastrointestinal tract houses a diverse array of probiotic and pathogenic bacteria
and any alterations in this microbial composition can exert a significant influence on an …

The Gram-positive anaerobic bacterium Clostridioides difficile (CD) can produce intense
exotoxins, contributing to nosocomial infections, and it is the most common cause of health …

Clostridioides difficile remains a problematic pathogen resulting in significant morbidity and
mortality, especially for high-risk groups that include immunocompromised patients. Both the …

Background: The COVID-19 pandemic has challenged the treatment of Clostridioides
Difficile (CD)-infected patients given the increasing number of co-infections with severe …

In a mutually beneficial connection with its host, the gut microbiota affects the host's nutrition,
immunity, and metabolism. An increasing number of studies have shown links between …

Clostridioides difficile is a Gram-positive bacteria that causes nosocomial infections,
significantly impacting public health. In the present study, we aimed to describe the clinical …

Summary The first British Society of Gastroenterology (BSG) and Healthcare Infection
Society (HIS)-endorsed faecal microbiota transplant (FMT) guidelines were published in …

The gut microbiota serves a crucial role in the development of host immunity.
Immunocompromised patients are particularly vulnerable to dysbiosis not only by virtue of a …

Up to 25% of patients recovering from antibiotic-treated Clostridioides difficile infection (CDI)
develop functional symptoms reminiscent of Post-Infectious Irritable Bowel Syndrome (PI …